Biological agents

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain
Thomas J Schnitzer, Evan F Ekman, Egilius L H Spierings, H Scott Greenberg, Michael D Smith, Mark T Brown, Christine R West, Kenneth M Verburg

Annals of the Rheumatic Diseases Jun 2015, 74 (6) 1202-1211; DOI: 10.1136/annrheumdis-2013-204905
Conventional DMARDs in axial spondyloarthritis: wishful––rather than rational—thinking!
Robert B M Landewé

Annals of the Rheumatic Diseases Jun 2015, 74 (6) 951-953; DOI: 10.1136/annrheumdis-2014-206758
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?
Karim Raza, Andrew Filer

Annals of the Rheumatic Diseases May 2015, 74 (5) 793-794; DOI: 10.1136/annrheumdis-2014-206993
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial
J S Smolen, P Emery, G F Ferraccioli, W Samborski, F Berenbaum, O R Davies, W Koetse, O Purcaru, B Bennett, H Burkhardt

Annals of the Rheumatic Diseases May 2015, 74 (5) 843-850; DOI: 10.1136/annrheumdis-2013-204632
Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis
L Yeo, H Lom, M Juarez, M Snow, C D Buckley, A Filer, K Raza, D Scheel-Toellner

Annals of the Rheumatic Diseases May 2015, 74 (5) 928-935; DOI: 10.1136/annrheumdis-2013-204116
High incidence of disease recurrence after discontinuation of disease-modifying antirheumatic drug treatment in patients with psoriatic arthritis in remission
Elizabeth G Araujo, Stephanie Finzel, Matthias Englbrecht, Dominik A Schreiber, Francesca Faustini, Axel Hueber, Kemal Nas, Juergen Rech, Georg Schett

Annals of the Rheumatic Diseases Apr 2015, 74 (4) 655-660; DOI: 10.1136/annrheumdis-2013-204229
Gastrointestinal events in at-risk patients starting non-steroidal anti-inflammatory drugs (NSAIDs) for rheumatic diseases: the EVIDENCE study of European routine practice
Angel Lanas, Maarten Boers, Javier Nuevo

Annals of the Rheumatic Diseases Apr 2015, 74 (4) 675-681; DOI: 10.1136/annrheumdis-2013-204155
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
Iain B McInnes, Liz Thompson, Jon T Giles, Joan M Bathon, Jane E Salmon, Andre D Beaulieu, Christine E Codding, Timothy H Carlson, Christian Delles, Janet S Lee, Naveed Sattar

Annals of the Rheumatic Diseases Apr 2015, 74 (4) 694-702; DOI: 10.1136/annrheumdis-2013-204345
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study
Burkhard Möller, Menno Pruijm, Sabine Adler, Almut Scherer, Peter M Villiger, Axel Finckh,

Annals of the Rheumatic Diseases Apr 2015, 74 (4) 718-723; DOI: 10.1136/annrheumdis-2013-204078
A8.9 Neutralisation of miR-155 ameliorates collagen-induced arthritis
BE Morton, S Neben, N Gibson, C McSharry, IB McInnes, M Kurowska-Stolarska

Annals of the Rheumatic Diseases Mar 2015, 74 (Suppl 1) A84-A85; DOI: 10.1136/annrheumdis-2015-207259.194

Main menu

Biological agents

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Biological agents

Pages